Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: history of present illness: the patient presented to hospital on with back pain and shortness of breath and was found on chest x-ray and ct to have pulmonary nodules, liver, and renal masses. she underwent biopsy of a left groin nodule and the skin nodule revealing melanoma and was diagnosed with metastatic melanoma. she was subsequently transferred to on for further management. on admission, her back pain was managed with ms contin with p.r.n. morphine with good response. a ct was negative for brain metastasis. she underwent a spinal mri to rule out cord compression which revealed multiple lytic lesions but no spinal cord compression. treatment options were discussed and high-dose il-2 therapy was recommended. she initiated high-dose il-2 on after undergoing central line placement in interventional radiology. during this week, she received doses of il-2 with course complicated by pulmonary edema. she was managed with oxygen supplementation and aggressive lasix diuresis as well as albuterol nebulizers. her respiratory status worsened over the next 36 hours, requiring icu transfer for aggressive diuresis and fluid management. she did not require intubation. she was treated with antibiotics for a possible pneumonia. she slowly improved with lasix diuresis and was transferred out of the icu on and was able to be discharged to home later that day when ambulating off o2 without noted hypoxia. other side effects during this week included rigors improved with demerol; nausea improved with antiemetic therapy; normal sinus tachycardia and development of an erythematous skin rash. during this week, she had no renal failure noted. she developed transaminitis with a peak alt of 156 and a peak ast of 200, both improved at the time of discharge. she developed hyperbilirubinemia with a peak bilirubin of 4.7 improved to 3.2 at the time of discharge. she was anemic without need for packed red blood cell transfusion. she developed thrombocytopenia with a platelet count low of 85,000 without evidence of bleeding. she had no myocarditis or coagulopathy noted. by , she had recovered from side effects to allow for discharge to home. condition on discharge: stable. discharge status: to home with her family. discharge diagnosis: metastatic melanoma status post cycle 1 week one high-dose il-2 therapy complicated by pulmonary edema. discharge medications: tylenol 1-2 tablets q.i.d. p.r.n. pain, zantac 150 mg p.o. b.i.d. p.r.n. indigestion, lorazepam 0.521 mg t.i.d. p.r.n. nausea/vomiting or anxiety, benadryl 25-50 mg q.i.d. p.r.n. pruritus, compazine 10 mg q.i.d. p.r.n. nausea/vomiting, lomotil 1-2 tabs q.i.d. p.r.n. diarrhea, eucerin cream topically, sarna lotion topically, ms contin 15 mg p.o. b.i.d., senna tablets 1-2 tablets p.o. b.i.d. p.r.n. constipation, oxycodone 5-10 mg every 4 hours p.r.n. pain, guaifenesin ml p.o. every 6 hours p.r.n. cough, nicotine patch 21 mg topically every 24 hours, levofloxacin 500 mg p.o. daily x3 days, miralax 17 grams p.o. daily p.r.n. constipation. follow-up plans: the patient will return in 1 week for week 2 of therapy assuming she recovers adequately. , procedure: venous catheterization, not elsewhere classified high-dose infusion interleukin-2 [il-2] diagnoses: pneumonia, organism unspecified anemia, unspecified tobacco use disorder malignant neoplasm of liver, secondary hypopotassemia anxiety state, unspecified acute respiratory failure other specified cardiac dysrhythmias antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use dermatitis due to drugs and medicines taken internally nausea alone secondary malignant neoplasm of lung disorders of magnesium metabolism secondary malignant neoplasm of bone and bone marrow acute edema of lung, unspecified secondary malignant neoplasm of kidney secondary and unspecified malignant neoplasm of lymph nodes of inguinal region and lower limb malignant melanoma of skin of lower limb, including hip 

Answer: The patient is high likely exposed to